Cutaneous squamous cell carcinoma clinical guideline
Guideline highlights
Tumor classification using the Brigham and Women's Hospital system is recommended for the most accurate prognostication in localized cSCC.
Stratification of localized cSCC using the National Comprehensive Cancer Network (NCCN) is recommended to provide practical clinical guidance for treatment of cSCC.
Biopsy techniques for cSCC are recommended, with the aim of identify techniques that provide optimal information for diagnosis and management of care.
In general, surgical therapy remains the most effective treatment for cSCC.
Nonsurgical therapies (radiation therapy, cryosurgery) may be selected for low-risk tumors or if surgery is contraindicated, with the understanding that the cure rate may be lower.
As there are limited treatment options for metastatic disease, early and complete treatment is important.
Patients diagnosed with cSCC should have annual checks for recurrence or other new primary skin cancer(s).
Full SCC guideline in JAAD
Read the squamous cell carcinoma guidelineView the AAD guidelines disclaimer.
Are you a patient with skin cancer?
See our AAD skin cancer pages for information on how to treat and manage your skin cancer.
Find a Dermatologist
Member directory
AAD Learning Center
2026 AAD Innovation Academy
Need coding help?
Reduce burdens
Clinical guidelines
Why use AAD measures?
New insights
Physician wellness
Joining or selling a practice?
Promote the specialty
Advocacy priorities